June 1, 2022 | Portfolio News
Moxe Health Raises $30M Series B to Further Advance Interoperability
Read More
Our Latest
December 23, 2021 | Portfolio News
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics
Read More
December 21, 2021 | Portfolio News
Apella Announces $21 Million Series A Funding to Digitize the Operating Room
Read More
December 14, 2021 | Portfolio News
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Read More
September 27, 2021 | Press Releases
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
September 27, 2021 MINNEAPOLIS & WASHINGTON, DC—(BUSINESS WIRE)—Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million in committed capital. The fund was oversubscribed at its hard cap with the support of the firm’s investors in its inaugural fund alongside select new institutional investors. Vensana Capital launched in 2019 […]
Read More
September 23, 2021 | Events Vensana in the News
Vensana’s Kirk Nielsen to Co-Chair the 2021 Medtech Venture & Partnering Conference in Minneapolis
Read More
June 30, 2021 | Portfolio News
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
Read More
June 21, 2021 | Portfolio News
This AI Startup Raised $43 Million To Save Lives (And Money) By Treating Heart Disease Earlier
Read More
June 21, 2021 | Portfolio News
Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease
Read More
May 27, 2021 | Portfolio News
GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate™ Cell Processing System for Next-Generation Cell & Gene Therapies
Read More
April 16, 2021 | Events
Vensana Capital Founders Offer Public Comments in Support of CMS Final Rule, “Medicare Program; Medicare Coverage of Innovative Technology (MCIT)”
Vensana Capital, a medical technology-focused venture capital firm based in Minneapolis and Washington, DC, is submitting this letter in response to the interim final rule delaying the effective date and requesting additional comment on the final rule establishing the MCIT coverage pathway for Food and Drug Administration (FDA)- designated breakthrough medical devices (“Notice of Delay”).1 […]
Read More
March 30, 2021 | Vensana in the News
NVCA Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
Read More
February 22, 2021 | Portfolio News
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Read More
February 9, 2021 | Events
Webinar: How Medtech Can Sustain Its Momentum in 2021: Strategies for Successful Investment, Co-Moderated by Justin Klein
Read More
January 7, 2021 | Portfolio News
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Read More
October 29, 2020 | Portfolio News
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Read More
September 7, 2020 | Portfolio News
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
Read More
July 8, 2020 | Portfolio News
CVRx® Raises $50 Million in New Equity Financing
Read More
June 15, 2020 | Events
Klein to speak at Life Sciences Future – MedTech
Read More
June 4, 2020 | Vensana in the News
Eight VCs Join NVCA Board and Barry Eggers of Lightspeed Appointed Chair
Read More
April 2, 2020 | Portfolio News
GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures
Read More
February 27, 2020 | Vensana in the News
Vensana—Is Medtech Investing on the Rebound?
Read More
October 8, 2019 | Vensana in the News
Medtech investor duo seeks to ‘fill the gap’ in device sector private funding
Read More
September 23, 2019 | Vensana in the News
New Minnesota-based fund has $225 million to invest in young med-tech companies
Read More
September 5, 2019 | Vensana in the News
New med-tech investment firm Vensana Capital launches $225 million fund
Read More
September 5, 2019 | Vensana in the News
Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund
Read More
September 4, 2019 | Vensana in the News
Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty
Read More
September 4, 2019 | Vensana in the News
New Medtech Investor Vensana Closes $225 Million Debut Fund
Read More
September 4, 2019 | Press Releases
Vensana Capital Launches with Inaugural $225 Million Fund
Read More
September 4, 2019 | Vensana in the News
Podcast: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana
Read More
August 12, 2019 | Events
Kirk Nielsen featured at MedTech Strategist Medical Alley Innovation Summit 2019
Read More
August 12, 2019 | Events
Vensana Capital Co-Organizes 26th Annual Phoenix Conference
Read More
June 14, 2019 | Events
TEDCO to Host Entrepreneur Expo on October 29 – Vensana Capital’s Justin Klein and AllegisCyber’s Bob Ackerman morning keynotes at the Expo
TEDCO’s annual Entrepreneur Expo was established to spotlight entrepreneurship in the region by bringing together Maryland’s various resources for a day of celebration.
Read More
June 10, 2019 | Events
Justin Klein featured at Virginia Bio Insights at University of Virginia Darden School of Business
Read More
May 31, 2019 | Portfolio News
Two medical device makers in Wayne get big boosts
Read More
May 30, 2019 | Portfolio News
Wayne medical device developer and its spin-off reel in $62 million
Read More
May 29, 2019 | Events
Kirk Nielsen to Co-Chair 2019 Medtech Investing Conference
Read More
May 29, 2019 | Portfolio News
Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™
Read More
May 29, 2019 | Portfolio News
Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®
Read More
May 29, 2019 | Portfolio News
Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases
Read More
May 13, 2019 | Events
Justin Klein featured at Pittsburgh Life Sciences Week 2019
Read More
May 2, 2019 | Events
Vensana Capital’s Cynthia Yee Keynotes Mayo Clinic and ASU MedTech Accelerator Investor Day: “Developing an ecosystem: strategies for assessing and mitigating risk in medtech investments.“
Read More
March 4, 2019 | Vensana in the News
Medical Device Investors Form New Medtech Venture Firm
Read More
